During the past decade, LLC "Novosibirsk GastroCenter" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LLC "Novosibirsk GastroCenter"" are "Crohn Disease" (2 trials). Many other conditions were trialed in "LLC "Novosibirsk GastroCenter"" in a lesser frequency.

Most popular intervention types in "LLC "Novosibirsk GastroCenter"" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC "Novosibirsk GastroCenter"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LLC "Novosibirsk GastroCenter"". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in LLC "Novosibirsk GastroCenter", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC "Novosibirsk GastroCenter", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".